Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: Clin Cancer Res. 2013 Feb 26;19(9):2528–2540. doi: 10.1158/1078-0432.CCR-12-3047

Figure 1.

Figure 1

Relative level of promoter hypermethylation of four target genes in tumors of ECOG 4393/RTOG9614 cohort included in this analysis (n=353). X-axis indicates methylation level of target genes normalized to β-Actin.